Skip to main content
NIH funding notice PAR-22-130

NIA Program Project Applications (P01 Clinical Trial Optional)

Closed on January 7, 2026.

Posted
March 10, 2022
Close date
January 7, 2026
Activity codes
Not stated on the notice page
Institutes taking part
Not stated on the notice page

Read the notice on Grants.gov · NIH Guide page

The notices it replaced

Its page was not saved, so the notices it replaced are not known.

Who won it before

11 competing awards (new and renewals) from FY2014 to FY2025 under this notice and the notices it replaced: $37,812,330 in first-year total cost, median $3,343,572.

Most frequent study sections

  1. Special Emphasis Panel[ZAG1 ZIJ-5 (M5)]1
  2. Special Emphasis Panel[ZAG1 ZIJ-8 (M1)]1
  3. Special Emphasis Panel[ZAG1 ZIJ-9 (M2)]1
  4. Special Emphasis Panel[ZAG1 ZIJ-D (J3)]1
  5. Special Emphasis Panel[ZAG1 ZIJ-G (M3)]1

Most frequent institutions

  1. COLUMBIA UNIVERSITY HEALTH SCIENCES2
  2. BOSTON UNIVERSITY MEDICAL CAMPUS1
  3. BROWN UNIVERSITY1
  4. DARTMOUTH COLLEGE1
  5. HARVARD MEDICAL SCHOOL1
Competing awards under PAR-22-130 and the notices it replaced
FYProjectPIsInstitutionFirst-year costStudy section
2025Bone as a Target and a Regulator of Aging2P01AG032959-16A1KARSENTY, GERARDCOLUMBIA UNIVERSITY HEALTH SCIENCES, NY$3,433,469ZAG1
2025SORL1 and its involvement in Alzheimer's disease pathogenesis and pathophysiology1P01AG090268-01A1PETSKO, GREGORY ASMALL, SCOTT ACOLUMBIA UNIVERSITY HEALTH SCIENCES, NY$3,184,272ZAG1
2025Medicare at a Crossroads2P01AG032952-16LANDON, BRUCE E.MCWILLIAMS, JOHN MICHAELHARVARD MEDICAL SCHOOL, MA$2,794,003ZAG1
2024Improving causal inference in Alzheimer's Disease prevention research on modifiable risk factors: the Triangulation of Innovative Methods to EndAD (TIME-AD) project1P01AG082653-01A1GILSANZ, PAOLAGLYMOUR, MEDELLENA MARIATORRES, JACQUELINE MARIEBOSTON UNIVERSITY MEDICAL CAMPUS, MA$5,262,301ZAG1
2024Mechanisms Underlying Heterogeneity of Cognitive Outcomes in Synucleinopathy1P01AG084497-01A1CHEN-PLOTKIN, ALICE SUNIVERSITY OF PENNSYLVANIA, PA$3,852,175ZAG1
2024Comparative genomics of longevity and Alzheimer's disease2P01AG047200-11GORBUNOVA, VERAUNIVERSITY OF ROCHESTER, NY$3,776,117ZAG1
2024Targeting Cellular Senescence to Extend Healthspan2P01AG062413-06KHOSLA, SUNDEEPLEBRASSEUR, NATHAN KMAYO CLINIC ROCHESTER, MN$3,544,455ZAG1
2024Understanding and Improving Healthcare Decision-Making and Outcomes for People Living with Alzheimer's Disease and Related Dementias2P01AG005842-35A1BAICKER, KATHERINESIMON, KOSALI ILAYPERUMANATIONAL BUREAU OF ECONOMIC RESEARCH, MA$3,185,633ZAG1
2024Alzheimer's Disease and Related Disorders Treatment and Outcomes in America: Changing Policies and Systems.2P01AG027296-16THOMAS, KALI ST. MARIETRIVEDI, AMAL N.BROWN UNIVERSITY, RI$2,878,793ZAG1
2024Molecular Regulation of Stem Cell Aging2P01AG036695-12A1RANDO, THOMAS A.UNIVERSITY OF CALIFORNIA LOS ANGELES, CA$2,557,540ZAG1
2023Causes and Consequences of Healthcare Inequity in Alzheimer's Disease and Related Dementias2P01AG019783-21BARNATO, AMBER EDARTMOUTH COLLEGE, NH$3,343,572ZAG1

Data: Grants.gov's daily extract and NIH's notice pages and award files, in ScienceGraph release conductgrants-2026-11-09-0.1.0. An award is listed only where NIH's own record names the notice, and a PI only by NIH's profile ID. Grants.gov and NIH do not endorse ScienceDex.

ScienceDex for faculty

Your academic CV and NIH biosketch

Make your CV in your school's format and your NIH biosketch from it, then download both as Word files.